Home
XRAY
XRAY News

Latest DENTSPLY SIRONA Inc. (XRAY) News on December 18, 2024

MT Newswires

a day ago

Morgan Stanley Cuts Price Target on DENTSPLY SIRONA to $23 From $30

Dentsply Sirona Declares Quarterly Cash Dividend

GlobeNewswire

5 days ago

Dentsply Sirona Declares Quarterly Cash Dividend

What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?

Benzinga

6 days ago

What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?

Argus Research

8 days ago

XRAY: Raising target price to $21.00

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

Zacks

9 days ago

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$19.46?

Simply Wall St.

13 days ago

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$19.46?

MT Newswires

14 days ago

Mizuho Initiates DENTSPLY SIRONA at Neutral With $21 Price Target

Argus Research

15 days ago

XRAY: What does Argus have to say about XRAY?

MT Newswires

15 days ago

Dentsply Sirona Names Herman Cueto Interim Finance Chief

Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswire

15 days ago

Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial Officer

GlobeNewswire

15 days ago

Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial Officer

MT Newswires

15 days ago

UBS Lowers Price Target on DENTSPLY SIRONA to $27 From $35, Keeps Buy Rating

Argus Research

22 days ago

XRAY: What does Argus have to say about XRAY?

Argus Research

a month ago

XRAY: Lowering target price to $19.00

Morningstar Research

a month ago

Analyst Report: DENTSPLY SIRONA Inc.

Dentsply (XRAY) International Revenue Performance Explored

Zacks

a month ago

Dentsply (XRAY) International Revenue Performance Explored

DENTSPLY SIRONA Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

DENTSPLY SIRONA Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Dentsply Sirona Inc (XRAY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

GuruFocus.com

a month ago

Dentsply Sirona Inc (XRAY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Morningstar Research

a month ago

Analyst Report: DENTSPLY SIRONA Inc.

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

a month ago

Sector Update: Health Care

MT Newswires

a month ago

Top Midday Decliners

MT Newswires

a month ago

Update: Dentsply Sirona Shares Fall After 2024 Outlook Cut

Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand

Benzinga

a month ago

Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand

XRAY Q3 Earnings & Revenues Beat Estimates, 2024 Guidance Revised

Zacks

a month ago

XRAY Q3 Earnings & Revenues Beat Estimates, 2024 Guidance Revised

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Premarket Thursday

Dentsply International (XRAY) Q3 Earnings and Revenues Beat Estimates

Zacks

a month ago

Dentsply International (XRAY) Q3 Earnings and Revenues Beat Estimates

MT Newswires

a month ago

Dentsply Sirona Q3 Adjusted Earnings, Revenue Increase; 2024 Outlook Lowered

Associated Press Finance

a month ago

Dentsply: Q3 Earnings Snapshot

Dentsply Sirona Reports Third Quarter 2024 Results

GlobeNewswire

a month ago

Dentsply Sirona Reports Third Quarter 2024 Results

Argus Research

a month ago

XRAY: Raising target price to $25.00

Should You Buy, Sell or Hold DENTSPLY SIRONA Before Q3 Earnings?

Zacks

a month ago

Should You Buy, Sell or Hold DENTSPLY SIRONA Before Q3 Earnings?

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

Zacks

2 months ago

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

Dentsply Sirona Shares Fall After Suspension of Byte Aligner Products

Zacks

2 months ago

Dentsply Sirona Shares Fall After Suspension of Byte Aligner Products

Insider Stock Buying Reaches US$1.21m On DENTSPLY SIRONA

Simply Wall St.

2 months ago

Insider Stock Buying Reaches US$1.21m On DENTSPLY SIRONA

Morningstar Research

2 months ago

Analyst Report: DENTSPLY SIRONA Inc.

Morningstar Research

2 months ago

Analyst Report: DENTSPLY SIRONA Inc.

Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products

GlobeNewswire

2 months ago

Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products

MT Newswires

2 months ago

Dentsply Sirona Suspends Sales of Byte Aligners; Reports Preliminary Q3 Results, Expected Impairment Charge

Dentsply Sirona Provides Update on Byte Aligner Products

GlobeNewswire

2 months ago

Dentsply Sirona Provides Update on Byte Aligner Products

Dentsply Sirona Sustainability Report 2023: Year of continued action leads to strong results and several goals achieved ahead of time

PR Newswire

2 months ago

Dentsply Sirona Sustainability Report 2023: Year of continued action leads to strong results and several goals achieved ahead of time

Dentsply Sirona to Host Third Quarter Conference Call on November 7th

GlobeNewswire

2 months ago

Dentsply Sirona to Host Third Quarter Conference Call on November 7th

Argus Research

2 months ago

XRAY: Lowering target price to $26.00

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

Zacks

3 months ago

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

Is DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Trading At A 20% Discount?

Simply Wall St.

3 months ago

Is DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Trading At A 20% Discount?

DENTSPLY SIRONA (XRAY) is Transforming In-House Denture Production

Insider Monkey

3 months ago

DENTSPLY SIRONA (XRAY) is Transforming In-House Denture Production

DENTSPLY SIRONA Stock May Gain on the Launch of Primescan 2

Zacks

3 months ago

DENTSPLY SIRONA Stock May Gain on the Launch of Primescan 2

Dentsply Sirona presents Primescan® 2 powered by DS Core: The first cloud-native intraoral scanning solution

PR Newswire

3 months ago

Dentsply Sirona presents Primescan® 2 powered by DS Core: The first cloud-native intraoral scanning solution

Dentsply Sirona to Participate in Upcoming Investor Conferences

GlobeNewswire

4 months ago

Dentsply Sirona to Participate in Upcoming Investor Conferences

Argus Research

4 months ago

XRAY: Raising target price to $27.00

Argus Research

4 months ago

XRAY: What does Argus have to say about XRAY?

Morningstar Research

4 months ago

Analyst Report: DENTSPLY SIRONA Inc.

MT Newswires

4 months ago

Dentsply Sirona Finance Chief Glenn Coleman to Resign

Dentsply Sirona Initiates Search for New CFO

GlobeNewswire

4 months ago

Dentsply Sirona Initiates Search for New CFO

DENTSPLY SIRONA Inc. (XRAY): Hedge Funds Are Bullish on This 3D Printing and Additive Manufacturing Stock Now

Insider Monkey

4 months ago

DENTSPLY SIRONA Inc. (XRAY): Hedge Funds Are Bullish on This 3D Printing and Additive Manufacturing Stock Now

Interpreting Dentsply (XRAY) International Revenue Trends

Zacks

4 months ago

Interpreting Dentsply (XRAY) International Revenue Trends

Earnings Miss: DENTSPLY SIRONA Inc. Missed EPS And Analysts Are Revising Their Forecasts

Simply Wall St.

4 months ago

Earnings Miss: DENTSPLY SIRONA Inc. Missed EPS And Analysts Are Revising Their Forecasts

MT Newswires

5 months ago

UBS Adjusts Dentsply Sirona Price Target to $35 From $34, Maintains Buy Rating

MT Newswires

5 months ago

Needham Adjusts Dentsply Sirona's PT to $34 From $36, Keeps Buy Rating

DENTSPLY SIRONA Second Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

5 months ago

DENTSPLY SIRONA Second Quarter 2024 Earnings: EPS Misses Expectations

Morningstar Research

5 months ago

Analyst Report: DENTSPLY SIRONA Inc.

Dentsply (XRAY) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks

5 months ago

Dentsply (XRAY) Reports Q2 Earnings: What Key Metrics Have to Say

DENTSPLY SIRONA (XRAY) Q2 Earnings Miss, Revenues Decline Y/Y

Zacks

5 months ago

DENTSPLY SIRONA (XRAY) Q2 Earnings Miss, Revenues Decline Y/Y

MT Newswires

5 months ago

Dentsply Sirona's Q2 Adjusted EPS, Revenue Decline; Lowers 2024 Guidance; Shares Drop 4% Pre-Bell

Dentsply International (XRAY) Q2 Earnings and Revenues Lag Estimates

Zacks

5 months ago

Dentsply International (XRAY) Q2 Earnings and Revenues Lag Estimates

Associated Press Finance

5 months ago

Dentsply: Q2 Earnings Snapshot

Dentsply Sirona Reports Second Quarter 2024 Results and Announces Second Phase of Transformation

GlobeNewswire

5 months ago

Dentsply Sirona Reports Second Quarter 2024 Results and Announces Second Phase of Transformation

Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?

Zacks

5 months ago

Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?

MT Newswires

5 months ago

UBS Adjusts Dentsply Sirona Price Target to $34 From $37, Maintains Buy Rating

What's in Store for DENTSPLY SIRONA (XRAY) in Q2 Earnings?

Zacks

5 months ago

What's in Store for DENTSPLY SIRONA (XRAY) in Q2 Earnings?

Labcorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

5 months ago

Labcorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now

Zacks

5 months ago

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

Zacks

5 months ago

Analysts Estimate Dentsply International (XRAY) to Report a Decline in Earnings: What to Look Out for

Argus Research

5 months ago

XRAY: Lowering target price to $27.00

MT Newswires

5 months ago

Baird Adjusts Price Target on Dentsply Sirona to $31 From $33, Maintains Neutral Rating

MT Newswires

5 months ago

Stifel Adjusts Price Target on Dentsply Sirona to $28 From $30, Maintains Hold Rating

Argus Research

5 months ago

XRAY: Raising target price to $28.00

DENTSPLY SIRONA (NASDAQ:XRAY) adds US$181m to market cap in the past 7 days, though investors from three years ago are still down 56%

Simply Wall St.

5 months ago

DENTSPLY SIRONA (NASDAQ:XRAY) adds US$181m to market cap in the past 7 days, though investors from three years ago are still down 56%

Argus Research

5 months ago

XRAY: Lowering target price to $25.00

MT Newswires

5 months ago

Evercore ISI Trims Price Target on Dentsply Sirona to $27 From $28, Maintains Outperform Rating

Dentsply Sirona to Host Second Quarter Conference Call on July 31st

GlobeNewswire

5 months ago

Dentsply Sirona to Host Second Quarter Conference Call on July 31st

Argus Research

6 months ago

XRAY: What does Argus have to say about XRAY?

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now

Zacks

6 months ago

Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now

MT Newswires

6 months ago

Evercore ISI Adjusts Price Target on Dentsply Sirona to $28 From $35, Maintains Outperform Rating

Here's Why We're Wary Of Buying DENTSPLY SIRONA's (NASDAQ:XRAY) For Its Upcoming Dividend

Simply Wall St.

6 months ago

Here's Why We're Wary Of Buying DENTSPLY SIRONA's (NASDAQ:XRAY) For Its Upcoming Dividend

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$26.11?

Simply Wall St.

6 months ago

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$26.11?

Dentsply Sirona Provides Update on June Investor Conference Participation

GlobeNewswire

6 months ago

Dentsply Sirona Provides Update on June Investor Conference Participation

California seeks company profits in Big Oil climate lawsuit

Reuters

6 months ago

California seeks company profits in Big Oil climate lawsuit

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

6 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

6 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

6 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

6 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Canada Border Strike Deadline Postponed for Mediation

Sourcing Journal

6 months ago

Canada Border Strike Deadline Postponed for Mediation

The Most Historic City in the United States

Insider Monkey

6 months ago

The Most Historic City in the United States

MT Newswires

6 months ago

Clearwater Analytics Holdings Insider Sold Shares Worth $2,375,416, According to a Recent SEC Filing

DENTSPLY SIRONA (XRAY) is Facing Turnaround Challenges

Insider Monkey

6 months ago

DENTSPLY SIRONA (XRAY) is Facing Turnaround Challenges

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

6 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

6 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

6 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

6 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Share on Social Networks: